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Abstract: 
RNA editing by members of the double-stranded RNA-specific ADAR family leads to 
site-specific conversion of adenosine to inosine (A-to-I) in precursor messenger RNAs. 
Editing by ADARs is believed to occur in all metazoa, and is essential for mammalian 
development. Currently, only a limited number of human ADAR substrates are 
known, while indirect evidence suggests a substantial fraction of all pre-mRNAs being 
affected. Here we describe a computational search for ADAR editing sites in the 
human transcriptome, using millions of available expressed sequences. 12,723 A-to-I 
editing sites were mapped in 1,637 different genes, with an estimated accuracy of 
95%, raising the number of known editing sites by two orders of magnitude. We 
experimentally validated our method by verifying the occurrence of editing in 26 
novel substrates. A-to-I editing in humans primarily occurs in non-coding regions of 
the RNA, typically in Alu repeats. Analysis of the large set of editing sites indicates the 
role of editing in controlling dsRNA stability. 
RNA editing by members of the double-stranded RNA-specific ADAR family leads to site-
specific conversion of adenosine to inosine (A-to-I) in precursor messenger RNAs1. 
ADAR-mediated RNA editing is essential for normal life and development in both 
invertebrates and vertebrates2-5.  ADAR-deficient inverterbrates show only behavioural 
defects2, 3, while ADAR1 knock-out mice die embryonically and ADAR2 null mice live to 
term but die prematurely4, 5. High editing levels were found in inflamed tissues6, in 
agreement with a proposed antiviral function of ADARs and their transcriptional regulation 
by interferon7.  Altered editing patterns were found in epileptic mice8, suicide victims 
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suffering chronic depression9, amyotrophic lateral sclerosis10 and in malignant gliomas11. 
Until recently only a handful of edited human genes were documented, most of which were 
discovered serendipitously12. A systematic experimental search for inosine-containing 
RNAs has yielded 19 additional cases13, and one further example was found using a cross-
genome comparison approach14. However, quantitation of inosine in total RNA suggests 
that editing affects a much larger fraction of the mammalian transcriptome15. In addition, 
tantalizing hints for abundant editing were observed in high-throughput cDNA sequencing 
data16. 
Large-scale identification of editing substrates by bioinformatics tools was previously 
considered practically impossible17. In principle, editing may be detected using the large-
scale database of ESTs18 (expressed sequence tags) and RNAs, which currently holds over 
5 million human records. Editing sites show up when a sequence is aligned with the 
genome: while the DNA reads A, sequencing identifies the inosine in the edited site as 
guanosine (G). However, the poor sequencing quality of the sequence database (up to 3% 
sequencing errors19) precludes a straightforward application of this approach. Moreover, 
millions of single nucleotide polymorphisms (SNPs) and mutations are erroneously 
identified as editing events by this method.  
Here we present a computational approach that overcomes these challenges. 12,723 A-to-I 
editing sites were mapped in 1,637 different genes, with an estimated accuracy of 95%. We 
thus raise the number of known editing sites by two orders of magnitude. Editing was 
experimentally validated in 26 of these 1,637 genes. The editing sites found are typically 
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located with Alu elements residing in non-coding regions of the RNA. The effect of  editing 
on dsRNA stability is analyzed. 
Results 
Computational identification of A-to-I editing 
ADAR substrates are usually imperfect dsRNA stems formed by base pairing of an exon 
containing the adenosine to be edited with a complementary portion of the pre-mRNA (up 
to several thousand nucleotides apart). We therefore restricted the search for mismatches to 
potential double-stranded regions, in order to remove most of the noise and facilitate the 
identification of true editing sites. For this purpose, human ESTs and cDNAs were aligned 
to the genome and assembled into clusters representing genes or partial genes. Details of 
this procedure are given in Sorek et al20. Then, our algorithm aligned the expressed part of 
the gene with the corresponding genomic region, looking for reverse complement 
alignments longer than 32 bp with identity levels higher than 85% (Fig. 1). About 429,000 
candidate dsRNAs were found in 14,512 different genes, mostly resulting from alignment 
of an exon (including the 3` and 5` UTRs) to an intron. In order to further decrease the 
number of random mismatches, SNPs and mutations, the algorithm then cleaned the 
sequences supporting the stem region. Since sequencing errors tend to cluster in certain 
regions, especially in low complexity areas and towards sequences ends, we discarded all 
single-letter repeats longer than 4 bp, as well as 150 bp at both ends of each sequence. In 
addition, all 50 nucleotides-wide windows in which the total number of mismatches is 5 or 
more were considered as having low sequencing quality and were discarded. However, 4 or 
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more identical sequential mismatches were masked in the count for mismatches in a given 
window. This exception is intended to retain sequences with many sequential editing sites, 
which were found to occur in previously documented examples21. Mismatches supported by 
less than 5% of available sequences were also discarded, and, finally, known SNPs of 
genomic origin were removed. Employing these criteria one finds that the putative editing 
sites tend to group together16, a fact which is also supported by the few available known 
cases13. Thus, all mismatches that occur less than three times in an exon were ignored.  
This above cleaning procedure resulted almost exclusively in A-to-G mismatches (Fig. 2a). 
Employing this procedure we identified 12,723 putative editing sites, belonging to 1,637 
different genes. The same approach applied to G-to-A mismatches yielded only 242 sites. 
Sequencing errors, SNPs and mutations, the three main sources of noise in our analysis, are 
expected to produce at least as many G-to-As as A-to-Gs (Fig. 2a,b,c). This signal-to-noise 
ratio (242/12723) suggests that our false positive rate is very low.  
Experimental Validation 
To experimentally validate the predicted editing sites, we chose 30 genes and sequenced 
matching DNA and RNA samples retrieved from the same specimen, for up to five tissues. 
We have positively verified editing events in 26 previously unknown editing substrates. 
PCR products were either cloned followed by sequencing of individual clones, or 
sequenced as a population, without cloning. When the PCR products were cloned, editing 
occurrence was detected by comparing the sequences of several clones with the genomic 
sequence (Fig. 3 and Supplementary Fig. 1). When PCR products were directly 
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sequenced, the occurrence of editing was determined by the presence of an unambiguous 
trace of guanosine in positions for which the genomic DNA clearly indicated the presence 
of an adenosine (Fig. 4). The full sequencing data are given as Supplementary Figure 2. 
We show here, for the first time, direct evidence for editing in liver, lung, kidney, prostate, 
colon, and uterus. For most genes, editing was found in all tissues, with varying relative 
abundance, but generally the unedited signal dominated the edited signal. Two genes were 
validated using cell-lines known to have varying levels of ADAR activity (Fig. 3). 
Interestingly, the observed levels of A-to-I conversions correlated well with the reported 
ADAR activities in these cell-lines22. Typically, additional editing sites, not present in our 
list, were found in the same region. The validation set was composed of two subsets: (i) 20 
genes for which the EST data suggested many putative editing events, 18 of these genes 
were confirmed to be edited. (ii) 17 genes were chosen randomly from the list of 1,637 
predicted genes. Four of these genes were discarded, as they did not allow for designing 
high-quality amplification primers outside the Alu sequence (see methods). 9 of the 
remaining 13 genes were successfully amplified and sequenced, 8 of which exhibited 
editing. Note that the success rate in our random subset (89%) is a lower bound to the true 
accuracy of the list, as either low editing efficiency at a given site or limited variety of 
tissues in our validation experiment could prevent the detection of editing events in the 
experimental sample. 
Characterization of the editing sites 
Interestingly, 92% of sites occur within an Alu repeat, and additional 1.3% lie within the 
primate-L1 repeat, in accordance with previous reports13, 16. This is explicable by the fact 
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that only long paired RNA molecules were scanned for editing, a structure more likely 
formed between repetitive elements. The distribution of editing sites within the Alu 
sequence exhibits a number of preferred edited adenosines, as well as adenosines unlikely 
to be edited. In particular, two specific A sites within the Alu repeat, in positions 27 and 28 
of Alu, account for ~12% of all editing events (see Supplementary Note). 
We have also found that G is underrepresented in the nucleotide upstream to the edited A, 
and overrepresented in the nucleotide following the editing site (see Supplementary Note), 
in accordance with previous reports23, 24. However, the fact that most of the sites occur 
within Alu repeats strongly biases the identification of additional significant patterns 
characterizing the editing site. 
Typically, editing is seen in only a fraction of the supporting expressed sequences (ESTs or 
cDNAs). In fact, for 83% of the sites only one sequence exhibits editing (after applying our 
cleaning filters). This suggests that editing does not occur with equal frequency in all 
tissues and conditions, and is of probabilistic nature. Our experimental data also support 
this finding.  
No specific expression pattern or Gene Ontology (GO) classification for the edited genes 
was found. However, we analysed the EST libraries searching for specific libraries showing 
an altered editing pattern. The libraries with the most significant over-editing pattern came 
from thymus, brain, pancreas, spleen and prostate (see Supplementary Note). Some of 
these observations support previous reports15, 25.  
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Editing can extend the proteomic diversity by changing the identity of a particular codon26, 
as the ribosome reads inosine as guanosine. Two novel examples of such editing are 
presented in the Supplementary Note. However, Morse et al. have predicted that most pre-
mRNA editing in the brain is located in non-coding regions21. In agreement with this, 
virtually all of the editing sites identified by us are located in non-coding regions: of the 
sites that can be aligned with RefSeq sequences, 12% were located in the 5’ UTR, 54% in 
the 3’ UTR and 33% are in RefSeq introns. Some of the sites annotated as introns might 
actually be within an alternative exon not covered by the RefSeq sequence. Note that our 
strict cleaning procedure definitely misses many true editing sites. In particular, the known 
examples of A-to-I editing in the Glutamate receptor and Serotonin receptor were not 
picked up by our algorithm, as the expressed part of the dsRNA supporting them were not 
long enough. Thus, it is likely that there are more editing sites within the coding region not 
detected in this work. 
It was suggested that one of the functions of RNA editing is the destabilization of dsRNAs. 
Our large database of editing sites enables us to test this prediction. ADAR-mediated 
editing of an A in an A-U base pair produces the less stable I-U pair, while A-C 
mismatches can be edited into the more stable I-C pairs. Looking at the best 
complementary alignment of the editing regions, we find that in 78% of the editing cases an 
A-U pair is destabilized, while in 19% an A-C pair is stabilized. Editing of either A-A or A-
G pairs occurs in only 3% of the cases. This suggests that editing is aimed at stabilization 
and destabilization only, and does not occur in situations where it has no major effect on 
dsRNA stability. Furthermore, the editing mechanism seems to prefer stabilization: 22% of 
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the editing events target a mismatched base-pair, while the average frequency of such 
mismatched base-pairs in the sites adjacent to the editing sites is only 10%, since these sites 
are all located in double-stranded regions. Thus, while most editing events result in 
destabilization of the dsRNA, we find many more stabilization events (i.e., editing of A-C 
to I-C) than what would be expected based on a random choice of the editing sites along the 
dsRNA. The preference towards stabilization editing is in agreement with previous 
reports27. 
Discussion 
This work increases the number of editing substrates by two orders of magnitude, in 
accordance with prior estimates15. This allows a large-scale analysis of the editing 
phenomenon. The widespread occurrence of editing makes it a significant contributor to the 
diversity of the transcriptome, producing presumably more different transcripts than 
produced by alternative splicing, while affecting only a small number of nucleotides. 
Interestingly, the large-scale editing in human is found to be strongly associated with Alu 
repeats, which are unique to primates. Thus, one does not expect the corresponding sites to 
be found in non-primate mammals. However, other repeats present in these organisms may 
be associated with the same phenomenon. The pronounced concentration of editing sites in 
Alu repeats raises that question whether A-to-I editing acts as an anti-transposition 
mechanism by inhibiting the integration of transcribed Alu back into the genome. Such a 
scenario is in agreement with an anti-viral mechanism of editing28, as retrotransposition of 
many repetitive elements is very similar to some stages of the retroviral infection. 
10 
Alternatively, Tonkin et al. suggest29 that editing regulates RNAi  by protecting the dsRNA 
from degradation. Our results indicate that these possible mechanisms may be of wide 
applicability. Finally, we note that there are probably many more sites than those listed in 
this work, since: (i) Editing happens in only a fraction of the sequences. Since the 
expressed sequence coverage of many genes is scarce, many editing sites might be absent 
from GenBank sequences. (ii) Our filtering parameters were chosen to minimize the noise, 
but inevitably miss many true sites such as the known sites in the glutamate receptor and 
serotonin 2c receptor pre-mRNAs9, 26. (iii) The experimental evidence show that a typical 
editing substrate contains more editing sites than the number predicted by us. Thus, the 
12,723 sites we listed may still represent only a portion of the actual editing repertoire. The 
large-scale mapping of editing sites enables the identification of new properties of non-
coding regions, and may facilitate the association of mutations in these regions with known 
pathologies. 
 
 
Methods 
Alignment of expressed sequences to the Genome 
Human ESTs and cDNAs were obtained from NCBI GenBank version 136 (June 
2003; www.ncbi.nlm.nih.gov/dbEST). The genomic sequences were taken from the human 
genome build 33 (June 2003; www.ncbi.nlm.nih.gov/genome/guide/human). 
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Briefly, sequences were aligned as follows: sequences were cleaned from terminal 
vector sequences, and low-complexity stretches and repeats (including Alu repeats) in the 
expressed sequences were masked. Then, expressed sequences were compared with the 
genome to find likely high-quality hits. They were then aligned to the genome by use of a 
spliced alignment model that allows long gaps. Only sequences having > 94% identity to a 
stretch in the genome were used in further stages. Further details can be found in Sorek at 
al20 . 
Experimental Methods 
Total RNA and genomic DNA (gDNA) isolated simultaneously from the same tissue 
sample were purchased from Biochain Institute. In this work we used samples of liver, 
prostate, uterus, kidney, colon, lung normal and tumor, brain tumor (glioma), cerebellum 
and frontal lobe. 
The total RNA underwent oligo-dT primed reverse transcription using Superscript II 
(Invitrogen, Carlsbad, CA) according to manufacturer instructions. The cDNA and gDNA 
(at 0.1 µg/µl) were used as templates for PCR reactions. We aimed at high sequencing 
quality and thus amplified rather short genomic sequences (roughly 200 bp). The amplified 
regions chosen for validation were selected only if the fragment to be amplified maps to the 
genome at a single site. PCR reactions were done using TaKaRa Ex Taq™ Hot Start 
(Takara Bio) using the primers and annealing conditions as detailed in the Supplementary 
Methods. The PCR products were run on 2% agarose gels and only if a single clear band of 
the correct approximate size was obtained, it was excised and sent to Hy-labs laboratories 
for purification and direct sequencing without cloning. 
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Poly-A RNA from tissue culture cells was isolated using Trifast (PeqLab) and poly-A 
selected using magnetic oligo dT beads (Dynal). 1µg of poly A RNA was reverse 
transcribed using random hexamers as primers and RNAseH deficient M-MLV reverse 
transcriptase (Promega). Genomic DNA from tissue culture cells was isolated according to 
Ausubel et al30. 
First strand cDNAs or corresponding genomic regions were amplified with suitable 
primers using Pfu polymerase, to minimize mutation rates during amplification. Amplified 
fragments were A-tailed using Taq polymerase, gel purified and cloned into pGem-T easy 
(Promega). After transformation in E. coli individual plasmids were sequenced and aligned 
using ClustalW. 
We used Contig Express software from Vector NTI 6.0 Suite (Informax, Inc.) for 
multiple-alignment of the electropherograms (see Supplementary Fig. 2). Typically, the 
extent of A-I editing is variable, e.g. the levels of the guanosine trace sometimes is only a 
fraction of the adenine trace, while in some occasions the conversion from A to I is almost 
complete. For each gene tested, we sequenced the three tissues in which the expression was 
the highest. The RT-PCR and gDNA-PCR of one of these tissues were sequenced from 
both ends to ensure the consistency of the resulting electropherograms.  
Information concerning the editing sites is available in: 
http://cgen.com/research/Publications/AtoIEditing  
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Figure 1:ADAR-mediated editing: a. pre-mRNA as transcribed from DNA. The gene 
contains two Alu repeats with opposite orientations, one of which overlaps with an exon. b 
The two oppositely oriented Alu sequences form a dsRNA structure. c An enzyme of the 
ADAR family edits some of the adenosines in the dsRNA structure into inosines. 
Figure 2: Distribution of mismatches between the DNA and the expressed RNA sequences 
that pass the cleaning algorithm. a: results of algorithm application to dsRNAs only. A-to-G 
mismatches clearly dominate the distribution. Notably, T-to-C mismatches are also 
overrepresented, likely being A-to-I editing events that were aligned to the opposite strand. 
Inset b shows the distribution of mismatches resulting from applying the algorithm to 
random expressed sequences covering about 20% of the transcriptome. Insets c and d show 
the distributions for known SNPs31 and mutations32, respectively. A-to-G mismatches do 
not stand out in the distributions b-d. 
Figure 3: Editing in the CFLAR transcript. A region corresponding to the 3' UTR of 
CFLAR was amplified from cDNAs and gDNA of neuroblastoma, HeLa and HeK293 cells. 
(A) schematic organization of CFLAR with predicted editing in the 3’UTR (brown 
shading). There are dozens of Alu elements within the genomic region of the CFLAR gene, 
and we can not tell for sure which one pairs with the above 3` UTR region (marked with a 
red arrow) to form the dsRNA required for editing. The closest Alu element is located on 
the 3` UTR as well, 1450 bp downstream (marked with a blue arrow). For this dsRNA, 
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virtually all editing events recorded in this figure result in destabilization of the dsRNA. (B) 
Sequences of individually cloned fragments were aligned to the published human genomic 
sequence. No A-to-I (reads as G in the sequence) conversion is found in HeK293 cells, 
while abundant and moderate editing is seen in neuroblastomas and HeLas, respectively. 
Editing events are highlighted in light brown shading. Nucleotides are numbered according 
to their position on chromosome 2. An additional example is provided in Supplementary 
Figure 1. 
Figure 4: Editing in the F11 receptor (JAM1) gene. Top: some of the publicly available 
expressed sequences covering this gene, together with the corresponding genomic 
sequence. The evidence for editing is highlighted. Bottom: Results of sequencing 
experiments. Matching DNA and cDNA RNA sequences for a number of tissues. Editing is 
characterized by a trace of guanosine in the cDNA RNA sequence, where the DNA 
sequence exhibits only adenosine signals (highlighted). 23 additional examples are 
provided in Supplementary Figure 2. Note the variety of tissues showing editing, and the 
variance in the relative intensity of the edited guanosine signal. 
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1. EST libraries 
 
 
We list here some EST libraries in which the fraction of ESTs showing RNA editing is 
significantly higher than the average. First, we count all ESTs that are edited at one or more 
sites out of the 12,723 sites in our database, and compare this number to the total number of 
ESTs covering these sites that do not exhibit editing (after the cleaning procedure is 
applied). We find that 6690 ESTs are edited and 4657 are not, giving an average editing to 
non-editing ratio of 6690:4657 or about 3:2. For each library we then calculate this ratio 
separately. We list here the libraries most significantly deviating from the 3:2 ratio (p-value 
calculated by the Fisher’s Exact Test). 
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Library name P-value Number of edited 
ESTs 
Number of ESTs 
not exhibiting 
editing 
tissue 
pBluescriptII SK plus   1.4e-9 60 5 Brain 
NIH_MGC_95 1.0e-9 74 9 Hyppocampus 
SPLEN2 5.6e-7 32 1 Spleen 
THYMU2 3.7e-7 37 2 Thymus 
NIH_MGC_110 2.2e-7 58 8 Pancreas 
BRACE2 1.3e-7 43 3 Cerebellum 
NIH_MGC_83 5.5e-5 44 8 Prostate 
CTONG2 5.0e-5 23 1 Tongue 
TRACH2 4.0e-5 19 0 Trachea 
Stratagene NT2 
neuronal precursor 
937230   
4.0e-5 19 0 Brain 
BRAMY2 1.7e-5 29 2 Amygdala 
NIH_MGC_41 1.4e-5 21 0 Cancer, skin 
 
 
 
 
 
19 
2. Nucleotides distribution  
 
In the following we look at the effect of RNA editing on the stability of its dsRNA 
substrates. For each predicted site, we search for its best opposite-strand alignment within 
the genomic region covered by the same gene cluster, and look at the effect of the editing 
on this alignment. First, we calculate the fraction of editing sites which are (before editing) 
matching to their opposite strand sequence. We find that 78.3% of the nucleotides in the 
editing sites match the opposite strand, and 21.7% are mismatched. This frequency of 
mismatches is actually much higher than could be expected by chance, given that the 
editing region as a whole is matched with average identity level of about 90%.  Indeed, the 
same analysis for the neighboring sites yields only 10.9% mismatches for the site upstream 
to the editing site, and 8.3% mismatches for the site downstream to the editing site. Thus 
the number of matching editing sites is actually lower than expected assuming a uniform 
distribution of the editing sites on the double-stranded regions. 
Next, we look at the distribution of nucleotides in the sites neighboring the editing sites, as 
well as the site located at the editing sites on the other strand. The distributions are 
presented in the following table: 
 
 A C G U 
Upstream site 29% 36% 6% 29% 
Downstream site 21% 22% 43% 14% 
Same site opposite strand 1.5% 18.9% 1.3% 78.3% 
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G is strongly underrepresented in the upstream preceding site, and overrepresented in the 
site following the editing site. However, one should be cautious in analyzing these patterns, 
as almost all sites are located within highly similar ALU repeats. The site opposed to the 
editing site is in most cases U, where editing changes the stable A-U pair into the less stable 
I-U pair. Among the cases in which the edited site is mismatched, the vast majority are C 
sites, where editing changes the less stable A-C pair into the more stable I-C pair. Changes 
that do not have a significant effect on the dsRNA stability, i.e., change of A-A pairs into I-
A pairs or change of A-G pairs into I-G pairs are rare. This suggests editing is directed at 
regulating the dsRNA stability. Moreover, the strong bias towards mismatches in the 
editing sites suggests editing is preferred where it stabilizes the dsRNA. 
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3. Editing sites and the ALU sequence 
 
ALU is a complex and diverse family of genomic repeats that are unique to the primates. 
Due to their ubiquity, it is probable that two oppositely oriented ALUs will be present in 
the same gene, and thus they are likely to form dsRNAs and putative editing sites. We thus 
compared our editing sites with the ALU repeat. In order to simplify the following analysis 
we concentrated on a “generic” ALU consensus sequence. We used the consensus of the 
Alu-J subfamily. The exact sequence that was used is gnl|alu|HSU14567. 
 
All 12,723 predicted editing sites were compared to the ALU sequence using the BLASTN 
program. The best same-strand hits to ALU were used. More than 93% of the sequences in 
the database had a significant (E-score <1e-10) match to the ALU consensus sequence. We 
retained only hits with at least 80% identity, which contain the predicted edited site in the 
alignment. We found 10,928 such hits, each assigning one editing site to a specific position 
on the ALU sequence.  
 
The ALU consensus sequence is 290 nt in length, and contains 67 A’s (23.1% of sequence). 
Of the 10,928 counts of predicted editing positions with alignments to ALU, 6,861 (63%) 
are in A positions. The remaining sites are almost exclusively located in G positions (i.e., a 
site which corresponds to a G in the ALU but actually shows A in the DNA, is edited to be 
G). This and more information is summarized in the following table: 
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Nucleotide Absolute 
frequency in 
ALU sequence 
Percentage in 
ALU sequence 
Number of 
predicted 
editing sites 
aligned to this 
nucleotide 
Percentage of 
predicted 
editing sites 
aligned to this 
nucleotide 
A 67 23.1% 6,861 63% 
C 82 28.3% 157 1.4% 
G 97 33.5% 3588 33% 
T 44 15.2% 293 2.7% 
 
 
In the following table we present the distribution of the 3,802 edited sites located in A 
positions and aligned to the Alu-J sequence, excluding reverse-complement alignments. It 
is shown that there are preferred positions for editing events in the alignment to ALU (p-
value calculated using the Z-test).  Note that positions 27,28 and 162 account for 19% of 
the positions aligned to A. This is a large bias suggesting that these 3 positions are in a 
place very favorable for RNA editing. In contrast, position 44 and 179 (only a few bases 
apart) has a counts of just 8 and 5, respectively, showing that these positions is unfavorable 
for predicted editing. Such very close positions with significantly different counts serve as 
ideal control for each other as there was no prior selection that preferred any of them. It is 
23 
also noteworthy that all A’s in the last 60bp of the sequence are significantly 
underrepresented. 
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Position of A in 
ALU 
Counts of predicted 
editing sites aligned 
to this position 
P-value of count 
being far from 
expected count 
(56.73 with std 
of 7.53) 
19 78 0.002 
27 221 < 1e-15 
28 249 < 1e-15 
33 71 0.03 
36 37 0.004 
44 8 5e-11 
50 48 0.123 
57 3 5e-13 
60 5 3e-12 
63 92 1e-6 
68 73 0.015 
73 135 < 1e-15 
76 19 3e-7 
82 93 7e-7 
84 27 4e-5 
87 72 0.021 
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96 65 0.14 
97 160 < 1e-15 
99 70 0.04 
101 85 9e-5 
105 51 0.22 
106 68 0.067 
107 133 < 1e-15 
118 110 8e-13 
120 11 6e-10 
121 114 1e-14 
122 76 0.005 
123 80 0.001 
124 69 0.052 
125 51 0.223 
127 127 < 1e-15 
129 19 3e-7 
130 52 0.26 
131 41 0.018 
132 78 0.002 
133 43 0.034 
136 181 < 1e-15 
162 248 < 1e-15 
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168 51 0.22 
172 105 7e-15 
179 5 3e-12 
185 43 0.034 
189 91 3e-06 
192 10 3e-10 
195 49 0.15 
203 71 0.029 
211 8 5e-11 
217 9 1e-10 
224 48 0.123 
228 51 0.223 
235 18 1e-7 
243 7 2e-11 
248 17 7e-8 
253 7 2e-11 
263 4 1e-12 
265 14 7e-9 
267 9 1e-10 
271 13 3e-9 
273 5 3e-12 
283 0 2e-14 
27 
284 1 7e-14 
285 1 7e-14 
286 0 2e-14 
287 2 2e-13 
288 0 2e-14 
289 0 2e-14 
290 0 2e-14 
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4. Putative editing sites in CDS 
 
HSPC274 
 
 
 
ATGGAGTCTAGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC genome 
ATGGAGTCTAGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTG TCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC AK055700 
ATGGAGTCTRGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC AF161392 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC BE866764 
ATGGAGTCTAGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC BG025753 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCGCCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC BE392757 
ATGGAGTCTAGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC BI907157 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCGGCTCACTGCAATCTCCGCCTCCTGGCTTCAGGCGATTCTTCTGCTTCAGCCTCC CB999681 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCC AGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC AA158593 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC BU959178 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC BG401333 
ATGGAGNNTAGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTNAAGCGATTCTTCTGCTTCAGCCTCC F06429 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCACCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC AL551550 
ATGGAGTCTGGTTCTGTCGCCCAGGCTGGAGCCCAGTGGTGTGATCTCAGCTCACTGCAATCTCCGCCTCCTGGCTTCAAGCGATTCTTCTGCTTCAGCCTCC BX441040 
  
 
 
In The HSPC274 (C20orf30) gene, exon 2 is an alternative ALU based exon.  The 
alternative exon contains a few putative editing sites, some of which are silent, but others 
cause replacement of amino acids: In the strongest site no AA is changed (position 10 
CTA>CTG L>L). However, transition of A>G at position 66 replaces His with Arg 
(CAC>CGC H>R). A Change of an AA is noted also in position 80 (AGC>GGC S>G) 
(ORF was taken from the AF161392 sequence) 
 
FLJ25952 
  
 
  
 
CTGGCGGATCACCTGAGGTCAGGGGTTCGAGATTAGCCTGGTCAAAATGGCAAAACCCTGTCTCCACTAAAAA     GENOME  
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CTGGCGGATCACCTGAGGTCAGGGGTTCGAGATTAGCCTGGTCAAAATGGCAAAACCCTGTCTCCACTAAAAA     AK090979  
CTGGCGGATCACCTGAGGTCAGGGGTTCGAGATTAGCCTGGTCAAAATGGCAAAACCCTGTCTCCACTAAAAA     AK098818  
CTGGCGGATCACCTGAGGTCAGGGGTTCGAGATTAGCCTGGTCAAAATGGCAAAACCCTGTCTCCACTAAAAA     NM153251  
------------------------GTTCGAGATTAGCCTGGTCAAGATGGCAAAACCCTGTCTCCACTAAAAA     W16480  
--------TCACCTGAGGTCAGGGGTTCGAGATTAGCCTGGTCAAAATGGCAAAACCCTGTCTCCACTAAAAA     BM556200  
CTGGCGGATCACCTGAGGTCAGGGGTTCGAGATTAGCCTGGTCGAAATGGCAAAACCCTGTCTCCACTAAAAA     BF207712  
CTGGCGGATCACCTGAGGTCAGGGGTTCGAGATTAGCCTGGTCGGGATGGCAAAACCCTGTCTCCACTAAAAA     CD518207  
 
 
 
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTAGTCCCAACTACTCGGGAGGTGGAGGCAGGAG     GENOME  
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTAGTCCCAGCTACTCGGGAGGTGGAGGCAGGAG     AK090979  
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTGGTCCCAACTACTCGGGAGGTGGAGGCAGGAG     AK098818  
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTGGTCCCAACTACTCGGGAGGTGGAGGCAGGAG     NM153251  
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTGGTCCCAACTACTCGGGAGGTGGAGGCAGGAG     W16480  
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTAGTCCCAACTACTCGGGAGGTGGAGGCAGGAG     BM556200  
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTGGTCCCAACTACTCGGGAGGTGGAGGCAGGAG     BF207712  
TACAAAAAAACCCCAAAACTGTCCAGGCATGGTGGCACACGCCTGTGGTCCCAGCTGCTCGGGAGGTGGAGGCAGGAG     CD518207 
 
 
 The hypothetical protein FLJ25952 contains a few putative editing sites. The sequence in 
genome positions 44-46 is tcaaaa (SK). Editing changes the sequence in one of a number of 
ways: tcgaaa (SK), tcaaga(SR), or tcggga(SG). 
 
Other potential editing sites in this exon are: position 120 agt> ggt S>G, position 127 aac > 
agc N>S, and position 130 tac>tgc Y >C. 
 
 
30 
Figure 1 
 
Figure 2 
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Figure 3  
 
 
 
 
a 
  
 
b 
 
Hek1    GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
Hek2    GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
HeLa1   GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
HeLa2   GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
HeLa3   GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
HeLa4   GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
HeLa5   GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
HeLa6   GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
NB1     GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
NB2     GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
NB3     GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
NB4     GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
NB5     GGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGAGGGCAGATCACTTCAGGTCA 
NB6     GGCTCACGCCTGTGGTCCCAGCACTTTGGGAGGCCGAGGAGGGCAGATCACTTCAGGTCG 
NB7     GGCTCACGCCTGTGGTCCCAGCACTTTGGGAGGCCGAGGAGGGCAGATCACTTCAGGTCG 
NB8     GGCTCGCACCTGTGGTCCCAGCACTTTGGGAGGCCGAGGAGGGCAGATCACTTCAGGTCG 
NB9     GGCTCGCGCCTGTGGTCCCAGCACTTTGGGAGGCCGAGGGGGGCAGATCACTTCAGGTCG 
NB10    GGCTCGCGCCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
NB11    GGCTCGCGCCTGTGGTCCCAGCACTTTGGGAGGCCGAGGAGGGCAGATCACTTCAGGTCA 
CHROMO1 GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGGTCACTTCAGGTCA 
CHROMO2 GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
CFLAR   GGCTCACACCTGTAATCCCAGCACTTTGGGAGGCCAAGGAGGGCAGATCACTTCAGGTCA 
 
Hek1    GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
Hek2    GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
HeLa1   GGAGCTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
HeLa2   GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
HeLa3   GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATGCAGAAAT 
HeLa4   GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
HeLa5   GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAGTACAAAAAT 
HeLa6   GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
NB1     AGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
NB2     GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
NB3     GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
NB4     GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
NB5     GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATGCAAAAAT 
NB6     GGGGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTGGAAATGCAGGAAT 
NB7     GGGGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTGGAAATGCAGGAAT 
NB8     GGAGTTCGAGACCAGCCTGGCCAGCATGGTAGACGCTGTCCCTAGTAGAAATGCAGAGGT 
NB9     GGAGTTCGAGACCAGCCTGGCCAACATGGTAGACGCTGTCCCTAGTAGAAGTACAGAAAT 
NB10    GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
NB11    GGGGTTCGAGACCGGCCTGGCCAACATGGTGGACGCTGTCCCTGGTAAAAGTGCAGAAAT 
CHROMO1 GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
CHROMO2 GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
CFLAR   GGAGTTCGAGACCAGCCTGGCCAACATGGTAAACGCTGTCCCTAGTAAAAATACAAAAAT 
 
Hek1    TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
Hek2    TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
HeLa1   TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
HeLa2   TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
HeLa3   TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
HeLa4   TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
HeLa5   TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
HeLa6   TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB1     TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB2     TAGCTGGGCGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB3     TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB4     TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB5     TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB6     TGGCTGGGTGTGGGTGTGGGTACCTGTGTTCCCAGTTACTTGGGAGGCTGGGGTGGGGGG 
NB7     TGGCTGGGTGTGGGTGTGGGTACCTGTGTTCCCAGTTACTTGGGAGGCTGGGGTGGGGGG 
NB8     TAGCTGGGTGTGGGTGTGGGTGCCTGTGTTCCCGGTTGCATGGGAGGCTGAGGTGGGAGG 
NB9     TAGCTGGGTGTGGGTGTGGGTACCTGTGTTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB10    TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
NB11    TGGCTGGGTGTGGGTGTGGGTACCTGTGTTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
CHROMO1 TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
CHROMO2 TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
CFLAR   TAGCTGGGTGTGGGTGTGGGTACCTGTATTCCCAGTTACTTGGGAGGCTGAGGTGGGAGG 
                        
GENOME   CAGGAGTTCAAGATCAGCCTGACCAACATGGAGAAACCCTACTAAAAA 
AI093487 CAGGAGTTCGGGATCAGCCTGACCAACATGGAGAAACCCTACTGGGAA 
BF771639 CGGGGGTTCGAGATCAGCCTGACCAACATGGAGAAACCCTACTGAAAA 
BM681047 CGGGAGTTCGGGATCAGCCTGACCAACATGGAGAAACCCTACTGAAAA 
BQ307221 CAGGAGTTCAGGATCAGCCTGACCAACATGGAGAAACCCTACTGNGAA 
R01692   CAGGAGTTCAGGATCAGCCTGACCAACATGGAGAAACCCTACTGGAAA 
BQ305305 CAGGAGTTCAGGATCAGCCTGACCAACATGGAGAAACCCTACTGGGAA 
AA101562 CGGGAGTTCGGGATCAGCCTGACCAACATGGAGAAACCCTACTGGAAA 
AW190875 CGGGAGTTCAGGATCAGCCTGACCAACATGGAGAAACCCTACTGGAAA 
BE350662 CGGGAGTTCGAGATCAGCCTGACCAACATGGAGAAACCCTGCTGAAAA 
AA149993 CGGGAGTTCGGGATCAGCCTGACCAACATGGAGAAACCCTACTGGGAA 
AI925871 CAGGAGTTCAAGATCAGCCTGACCAACATGGAGAAACCCTACTAAAAA 
AI333843 CGGGAGTTCAGGATCAGCCTGACCAACATGGAGAAACCCTACTGGGAA 
AW338261 CAGGAGTTCGGGATCAGCCTGACCAACATGGAGAAACCCTACTGGAAA 
 
   
               
   
   
               
gDNA liver 
gDNA lung 
RNA liver 
RNA lung 
RNA brain 
 
RNA kidney 
 
   
